Ashwini Neelgund
Psychosomatic Medicine · Matawan, NJNPI 1487869574
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 507 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations.
Across 507 payments — averaging $15.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sunovion Pharmaceuticals Inc.$809
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$807
- Otsuka America Pharmaceutical, Inc.$727
- Takeda Pharmaceuticals U.S.A., Inc.$584
- Teva Pharmaceuticals USA, Inc.$481
- plus $3K from 23 others
What the payments were for
- Food & beverage$7,85899%
- Education$601%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 99 | $1,533 |
| Sunovion Pharmaceuticals Inc. | 69 | $809 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 41 | $807 |
| Otsuka America Pharmaceutical, Inc. | 51 | $727 |
| Takeda Pharmaceuticals U.S.A., Inc. | 44 | $584 |
| Teva Pharmaceuticals USA, Inc. | 29 | $481 |
| Jazz Pharmaceuticals Inc. | 23 | $320 |
| Alkermes, Inc. | 19 | $316 |
| Neos Therapeutics, LP | 19 | $312 |
| Bausch Health US, LLC | 14 | $249 |
| E.r. Squibb & Sons, L.L.C. | 8 | $245 |
| Vanda Pharmaceuticals Inc. | 16 | $233 |
| Neurocrine Biosciences, Inc. | 5 | $184 |
| Corium, LLC | 16 | $179 |
| Abbott | 8 | $176 |
| Johnson & Johnson | 7 | $128 |
| Almatica Pharma LLC | 8 | $125 |
| Axsome Therapeutics, Inc. | 7 | $118 |
| Lundbeck LLC | 6 | $84 |
| Supernus Pharmaceuticals, Inc. | 2 | $79 |
| Eisai Inc. | 5 | $66 |
| Sage Therapeutics, LLC | 2 | $35 |
| Validus Pharmaceuticals LLC | 2 | $29 |
| Shire North American Group Inc | 2 | $26 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Tris Pharma Inc | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few psychosomatic medicine providers in New Jerseyto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 25 | $57,188 |
| AtivanLorazepam | 12 | $32,715 |
| Clozapine OdtClozapine | 11 | $19,838 |
| VraylarCariprazine Hcl | 14 | $18,194 |
| AdderallDextroamphetamine/Amphetamine | 11 | $10,443 |
| TrintellixVortioxetine Hydrobromide | 18 | $10,240 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 77 | $5,268 |
| Adderall XrDextroamphetamine/Amphetamine | 18 | $3,951 |
| Alprazolam | 368 | $3,210 |
| Doxepin Hcl | 15 | $3,048 |
| Aripiprazole | 97 | $2,823 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 103 | $2,796 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 35 | $2,219 |
| Lisdexamfetamine Dimesylate | 13 | $2,213 |
| Oxcarbazepine | 39 | $2,210 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $727 | $57,18825 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Adderall, Trintellix | $584 | $20,68329 claims |
| AbbVieVraylar | $1,533 | $18,19414 claims |
| Almatica Pharma LLCSertraline Hcl | $125 | $1,099114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few psychosomatic medicine providers in New Jerseyon file to place this against a meaningful peer group, so we don't.
Other psychosomatic medicine in Matawan
- Pamela WilliamsPassaic$7K
- Frederick KahnParamus$2K
- Ayman RamzySkillman$974
- Jan ChrobokGillette$744
- Adriana PhanHackensack$455
- Thomas CampoCherry Hill$116
- Annamaria NucciCedar Grove$110
- Justin CapoteMontclair$101
- Nina SugarRidgewood$49
- Lawrence EisensteinRed Bank$15
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.